Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
OB-002
DRUG
2 trials
Sponsors
Orion Biotechnology Polska Sp. z o.o.
Conditions
HIV Prevention
Metastatic Breast Cancer
Metastatic Cancer
Metastatic Colorectal Cancer
Metastatic Gastric Cancer
Metastatic Pancreatic Cancer
Metastatic Urothelial Carcinoma
Early Phase 1
OB-002H Gel Administered Vaginally and Rectally in HIV-1 Seronegative Adults
Completed
NCT04791007
Orion Biotechnology Polska Sp. z o.o.
HIV Prevention
Start: 2019-10-05
End: 2020-08-31
Updated: 2021-03-18
Phase 1
Study of OB-002 in Patients With Refractory Metastatic Cancer
Withdrawn
NCT05940844
Orion Biotechnology Polska Sp. z o.o.
Metastatic Breast Cancer, Metastatic Cancer, Metastatic Colorectal Cancer +3
Start: 2024-01-31
End: 2025-08-31
Updated: 2025-04-09
Related Papers
Evaluation of the Safety, Acceptability, and Pharmacokinetic Profile of a Gel Formulation of OB-002 in Healthy Volunteers
AIDS Research and Human Retroviruses
2021-03-22
6 citations